The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The 4 ounce jar is white with a lime green and pink printed label and has a white dome cap. The 2.2 ounce tube is white with a lime green and pink printed label. The lot numbers and expiration dates of the affected products can be found on the bottom of the jar and on the front of the crimped end of the tube. “TriDerma Pain Relief Cream” is printed on the jar and tube.
|Lot Number||Expiration Date|
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.